Adham Jurdi, Sr Medical Director of GI Oncology and Innovations at Natera, shared a post on LinkedIn:
“I’m happy to share that I’m starting a new position as Sr Medical Director, GI Oncology and Innovations at Natera
In this expanded role, I’ll continue to lead our GI oncology efforts while helping drive Natera’s oncology innovation pipeline – integrating ctDNA/MRD, digital pathology, ML/ AI, and multi-omics into translational frameworks that directly inform clinical decision-making and patient care.
I’ll be at GI26 and would love to connect with colleagues and collaborators who are interested in pushing the boundaries of innovation in GI oncology – from MRD-guided trials to multi-modal biomarkers and beyond.
Feel free to reach out or say hello in person.”
More posts featuring Adham Jurdi.